According to data disclosed by the Drug Controller-General of India, during the period (January 2008- January 2012), India recorded 2061 drug trial-related deaths. Maharashtra recorded the maximum number of 268 deaths due to SAEs (Serious Adverse Events) during drug trials while Madhya Pradesh recorded the least number of such deaths.
It is followed by Andhra Pradesh-153, Delhi/National Capital Region -97, Gujarat -87 and Karnataka -78. The number of deaths in Maharashtra was over 10 times that of Madhya Pradesh.
Comments
All Comments (0)
Join the conversation